@article{fcab434ead7f4ce2b7d4d07eb366f7c8,
title = "Characteristics of long-term and short-term survivors of metastatic renal cell carcinoma treated with targeted therapies: Results from the international mrcc database consortium",
author = "Fay, {Andr{\'e} P.} and Xie, {Wanling L.} and Lee, {Jae Lyn} and Harshman, {Lauren C.} and Bjarnason, {Georg A.} and Knox, {Jennifer J.} and Scott Ernst and Lori Wood and Vaishamayan, {Ulka N.} and Takeshi Yuasa and Tan, {Min Han} and Rha, {Sun Young} and Frede Donskov and Neeraj Agarwal and Kollmannsberger, {Christian K.} and North, {Scott A.} and Rini, {Brian I.} and Choueiri, {Toni K.} and Heng, {Daniel Y.C.}",
note = "Funding Information: This work was conducted as part of the IMDC database. We thank the DF/HCC Kidney Cancer SPORE, Trust Family, and the Michael Brigham Funds for Kidney Cancer Research (T.K.C.). This work was supported in part by DF/HCC Kidney Cancer SPORE P50 CA101942-01 . Funding Information: L.C.H.: Advisory boards at Aveo, Pfizer, Bristol-Myers Squibb; Past research funding: BMS, Novartis. M.H.T. has filed for patents on molecular predictors of survival, drug response, and toxicity in patients with RCC. U.N.V.: Consultant speaker and research support from Novartis and speaker for Pfizer. J.J.K.: Research support: Pfizer and Novartis. G.A.B.: Speaker for Pfizer, GSK, and Novartis; grant support from Pfizer. T.K.C.: Consultancy: Pfizer, Novartis; Advisory board: Pfizer, Novartis, Aveo, GlaxoSmithKline, Exelixis; Research: Pfizer; No Speakers bureau. C.K.: Advisory roles at Pfizer, Novartis, and GlaxoSmithKline; Honoraria and research funding from Pfizer, Novartis, and GlaxoSmithKline. B.I.R.: Advisory role at Pfizer, GlaxoSmithKline, Aveo, Bayer, Onyx, and has received research funding from GlaxoSmithKline and Pfizer. F.D.: Research grants from Novartis and GSK. L.W.: Research: Pfizer, Novartis, GSK; advisory boards, but no financial compensation, from Pfizer and Novartis. D.Y.C.H.: Consultancy: Bayer, Novartis, and Pfizer. All remaining authors have declared no conflicts of interest. Publisher Copyright: {\textcopyright} 2015 Elsevier Inc. All rights reserved.",
year = "2015",
month = apr,
day = "1",
doi = "10.1016/j.clgc.2014.09.003",
language = "English",
volume = "13",
pages = "150--155",
journal = "Clinical Genitourinary Cancer",
issn = "1558-7673",
publisher = "Elsevier",
number = "2",
}